Jundishapur Journal of Microbiology

Published by: Kowsar

Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination

Mohammad Hosein Sarmast Shooshtari 1 , 2 , Manoochehr Makvandi 1 , 3 , 4 , Mojtaba Rasti 3 , * , Niloofar Neisi 1 , 3 , Nasrin Rastegarvand 3 , Amir Pouremamali 3 , Mehrdad Sadeghi Haj 3 and Fardin Ghaedi 5
Authors Information
1 Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of General Surgery, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Deputy of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 2015, 8 (1); e59742
  • Published Online: December 6, 2014
  • Article Type: Research Article
  • Received: July 25, 2013
  • Revised: September 24, 2013
  • Accepted: October 6, 2013
  • DOI: 10.5812/jjm.13801

To Cite: Sarmast Shooshtari M H, Makvandi M, Rasti M, Neisi N, Rastegarvand N, et al. Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination, Jundishapur J Microbiol. 2015 ; 8(1):e59742. doi: 10.5812/jjm.13801.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol. 2004; 173(9): 5863-71[PubMed]
  • 2. Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011; 11(2): 99-102[PubMed]
  • 3. Di Giuseppe G, Nobile CG, Marinelli P, Angelillo IF. A survey of knowledge, attitudes, and behavior of Italian dentists toward immunization. Vaccine. 2007; 25(9): 1669-75[DOI][PubMed]
  • 4. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997; 157(22): 2601-5[PubMed]
  • 5. Wang J, Gujar SA, Cova L, Michalak TI. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. J Virol. 2007; 81(2): 903-16[DOI][PubMed]
  • 6. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996; 4(1): 25-36[PubMed]
  • 7. Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006; 24(21): 4482-9[DOI][PubMed]
  • 8. Mast E, Mahoney F, Kane M, Margolis H. Vaccines. 2004; : 299 –337
  • 9. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004; 351(27): 2832-8[DOI][PubMed]
  • 10. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991; 40: 1-25[PubMed]
  • 11. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998; 15(1): 73-7[PubMed]
  • 12. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005; 118 Suppl 10A: 34S-9S[DOI][PubMed]
  • 13. Hamidi B, Bahadori M, Mansouri S, Nategh R. Seroepidemiological survey of hepatitis B markers in National Iranian Oil Company (NIOC) health workers in Tehran prior to mass vaccination. Arch Irn Med. 2000; 3: 1-5
  • 14. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006; 18(4): 4-9[PubMed]
  • 15. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine. 2008; 26(2): 269-76[DOI][PubMed]
  • 16. Alavian SM, Mansouri S, Abouzari M, Assari S, Bonab MS, Miri SM. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005). Eur J Gastroenterol Hepatol. 2008; 20(2): 131-4[DOI][PubMed]
  • 17. Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis. 2010; 5(1): 45-50
  • 18. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008; 197(10): 1419-26[DOI][PubMed]
  • 19. Saberifiroozi M, Gholamzadeh S, Serati AR. The long-term immunity among health care workers vaccinated against hepatitis B virus in a large referral hospital in southern Iran. Arch Iran Med. 2006; 9(3): 204-7[PubMed]
  • 20. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific Adaptive Immunity. Viruses. 2009; 1(2): 91-103[DOI][PubMed]
  • 21. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol. 2013; 4(1): 24-7[DOI][PubMed]
  • 22. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol. 2002; 55(3): 311-4[PubMed]
  • 23. Jafarzadeh A, Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma Immunol. 2012; 11(4): 308-15[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments